|
|
|
|
| LEADER |
01000cam a2200265 c4500 |
| 001 |
384966721 |
| 003 |
DE-627 |
| 005 |
20230905073608.0 |
| 007 |
tu |
| 008 |
040413s2004 gw ||||| 00| ||eng c |
| 020 |
|
|
|a 3540406409
|9 3-540-40640-9
|
| 035 |
|
|
|a (DE-627)384966721
|
| 035 |
|
|
|a (DE-599)GBV384966721
|
| 035 |
|
|
|a (OCoLC)176874933
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XA-DE
|c XD-US
|c XB-CN
|
| 084 |
|
|
|a 15,3
|2 ssgn
|
| 084 |
|
|
|a 35.76
|2 bkl
|
| 090 |
|
|
|a a
|
| 245 |
1 |
0 |
|a Angiotensin
|n Vol. 1 / contributors E. M. Abdel-Rahman ...
|c ed. Thomas Unger ...
|
| 264 |
|
1 |
|a Berlin [u.a.]
|b Springer
|c 2004
|
| 300 |
|
|
|a XIII, 548 S.
|b Ill., graph. Darst.
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 490 |
1 |
|
|a Handbook of experimental pharmacology
|v 163,1
|
| 500 |
|
|
|a Literaturangaben
|
| 700 |
1 |
|
|a Abdel-Rahman, E. M.
|4 oth
|
| 700 |
1 |
|
|a Unger, Thomas
|d 1950-
|0 (DE-588)120127741
|0 (DE-627)080464696
|0 (DE-576)188155724
|4 oth
|
| 773 |
1 |
8 |
|w (DE-627)384966284
|g Vol. 1
|q 1.2004
|7 nnnm
|
| 830 |
|
0 |
|a Handbook of experimental pharmacology
|v 163,1
|9 16301
|w (DE-627)397619103
|w (DE-576)9397619101
|w (DE-600)2163658-8
|x 0171-2004
|7 ns
|
| 856 |
4 |
2 |
|u http://www.gbv.de/dms/bs/toc/384966721.pdf
|m V:DE-601
|m B:DE-84
|q pdf/application
|x Verlag
|y Inhaltsverzeichnis
|3 Inhaltsverzeichnis
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a ISIL_DE-1a
|
| 912 |
|
|
|a SYSFLAG_1
|
| 912 |
|
|
|a GBV_KXP
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a SSG-OPC-PHA
|
| 912 |
|
|
|a SSG-OPC-DE-84
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a ISIL_DE-84
|
| 912 |
|
|
|a GBV_ILN_21
|
| 912 |
|
|
|a ISIL_DE-46
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a ISIL_DE-18
|
| 912 |
|
|
|a GBV_ILN_22_i06404
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a ISIL_DE-8
|
| 912 |
|
|
|a GBV_ILN_31
|
| 912 |
|
|
|a ISIL_DE-27
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a ISIL_DE-7
|
| 912 |
|
|
|a GBV_ILN_65
|
| 912 |
|
|
|a ISIL_DE-3
|
| 912 |
|
|
|a GBV_ILN_65_a024
|
| 912 |
|
|
|a GBV_ILN_69
|
| 912 |
|
|
|a ISIL_DE-9
|
| 912 |
|
|
|a GBV_ILN_74
|
| 912 |
|
|
|a ISIL_DE-354
|
| 935 |
|
|
|i sf
|
| 936 |
b |
k |
|a 35.76
|j Aminosäuren
|j Peptide
|j Eiweiße
|x Biochemie
|0 (DE-627)181571129
|
| 951 |
|
|
|a MV
|
| 980 |
|
|
|2 11
|1 01
|x 0001
|b 650394321
|c 00
|f 2
|d 322790-Erg.,163,1
|e u
|j --%%--
|y k
|z 10-06-04
|
| 980 |
|
|
|2 20
|1 01
|x 0084
|b 64380854X
|c 00
|f --%%--
|d 2834-1330
|e --%%--
|j --%%--
|y k
|z 23-04-04
|
| 980 |
|
|
|2 21
|1 01
|x 0046
|b 64250735X
|c 00
|f E02
|d h med 513 d/58-163,1
|e d
|j --%%--
|y zza
|z 13-04-04
|
| 980 |
|
|
|2 22
|1 01
|x 0018
|b 643913793
|c 00
|f 18/64
|d WG 106 Med A 1934/12: 163,1
|e u
|j --%%--
|c 03
|f --%%--
|d Med A 1934/12: 163,1
|e --%%--
|j --%%--
|y zi06404
|z 23-04-04
|
| 980 |
|
|
|2 24
|1 01
|x 8/202
|b 642672016
|c 00
|f 29
|d MR 79-NS163,1
|e u
|j --%%--
|h ma
|y zz1
|z 14-04-04
|
| 980 |
|
|
|2 31
|1 01
|x 0027
|b 664588468
|c 00
|f Mag3
|d Mag3 B 2364
|e u
|j --%%--
|y z
|z 21-09-04
|
| 980 |
|
|
|2 40
|1 01
|x 7/11
|b 647800012
|c 00
|f BBM
|d XS 351 015 = 4 MAT MED 70/9:163,1
|e s
|j --%%--
|c 09
|f --%%--
|d 4 MAT MED 70/9:163,1
|e --%%--
|j --%%--
|y xsn
|z 01-06-04
|
| 980 |
|
|
|2 65
|1 01
|x 3/150
|b 644069236
|c 00
|f Ha 150
|d XI 1700 101 (163,1)
|e u
|j --%%--
|c 08
|f Ha 150
|d LS 44.38/1999:0004 (163,1)
|e --%%--
|j --%%--
|c 09
|f Ha 6F
|d Aa 105/224 A
|e --%%--
|j --%%--
|y za024
|z 26-04-04
|
| 980 |
|
|
|2 69
|1 01
|x 0009
|b 687464951
|c 00
|f UB 660
|d 660/XI 1701 H461-163,1
|e u
|j --%%--
|y z
|z 07-12-04
|
| 980 |
|
|
|2 74
|1 01
|x 0354
|b 643690913
|c 00
|f Magazin
|d M 2640a-163,1
|e u
|j --%%--
|y r
|z 07-02-18
|
| 982 |
|
|
|2 74
|1 00
|x DE-354
|8 00
|a Angiotensins-physiology
|
| 982 |
|
|
|2 74
|1 00
|x DE-354
|8 01
|a Receptors, Angiotensin-physiology
|
| 982 |
|
|
|2 74
|1 00
|x DE-354
|8 02
|a Renin Angiotensin System-genetics
|
| 982 |
|
|
|2 74
|1 00
|x DE-354
|8 03
|a Renin Angiotensin System-physiology
|
| 982 |
|
|
|2 74
|1 00
|x DE-354
|8 04
|a Angiotensin Converting Enzyme Inhibitors-pharmacokinetics
|
| 983 |
|
|
|2 24
|1 01
|x 8/202
|8 50
|0 (DE-627)058022015
|a mdm 453.200
|b Kinine. Renin-Angiotensin-System
|
| 983 |
|
|
|2 24
|1 01
|x 8/202
|8 70
|0 (DE-627)571540759
|a mdm 453
|b Hormon
|
| 983 |
|
|
|2 69
|1 00
|x DE-9
|8 00
|a XI 1701
|
| 983 |
|
|
|2 74
|1 00
|x DE-354
|8 00
|a QV 34
|
| 984 |
|
|
|2 11
|1 01
|x 0001
|a 141415163010
|
| 984 |
|
|
|2 20
|1 01
|x 0084
|a 84$028341330
|
| 984 |
|
|
|2 22
|1 01
|x 0018
|a 056997848
|
| 984 |
|
|
|2 24
|1 01
|x 8/202
|a 8$0000962120
|
| 984 |
|
|
|2 31
|1 01
|x 0027
|a 27$014152452
|
| 984 |
|
|
|2 40
|1 01
|x 7/11
|a 7$214963098
|
| 984 |
|
|
|2 65
|1 01
|x 3/150
|a 3/150$00207055
|
| 984 |
|
|
|2 69
|1 01
|x 0009
|a 9$06205593
|
| 984 |
|
|
|2 74
|1 01
|x 0354
|a 354$12237825
|
| 985 |
|
|
|2 21
|1 01
|x 0046
|a ab 1658-163,1
|
| 985 |
|
|
|2 22
|1 01
|x 0018
|a uke2004. 907
|
| 985 |
|
|
|2 31
|1 01
|x 0027
|a C 91242
|
| 985 |
|
|
|2 65
|1 01
|x 3/150
|a 6F/2004/00014
|
| 985 |
|
|
|2 69
|1 01
|x 0009
|a 2004.16064
|
| 985 |
|
|
|2 74
|1 01
|x 0354
|a M 2640a-163,1
|
| 995 |
|
|
|2 24
|1 01
|x 8/202
|a ma
|
